Evidence map›Paper›PMID 31705720›Full record

ArticlePlant biotechnology journal2020

Engineering bacteriocin-mediated resistance against the plant pathogen Pseudomonas syringae.

William M Rooney, Rhys W Grinter, Annapaula Correia, Julian Parkhill, Daniel C Walker, Joel J Milner

Open access · goldAbstract read
In one paragraph

Article in Plant biotechnology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Screening ofMicroorganisms · 2022
    Article
  12. Review
  13. Review
  14. Review
  15. A novel of new class II bacteriocin fromFrontiers in microbiology · 2022
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

William M RooneyPlant Science Group, Institute of Molecular, Cell and Systems Biology & School of Life Sciences, University of Glasgow, Glasgow, UK.
Rhys W GrinterInstitute of Infection, Immunity & Inflammation, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0002-8195-5348
Annapaula CorreiaWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Julian ParkhillWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.ORCID 0000-0002-7069-5958
Daniel C WalkerInstitute of Infection, Immunity & Inflammation, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0002-4206-2942
Joel J MilnerPlant Science Group, Institute of Molecular, Cell and Systems Biology & School of Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0003-3702-4295
Glasgow Life · GBUniversity of Glasgow · GBWellcome Sanger Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L02022X/1Wellcome TrustWellcome Trust 201505/Z/16/Z
6 · The paper itself

Abstract

The plant pathogen, Pseudomonas syringae (Ps), together with related Ps species, infects and attacks a wide range of agronomically important crops, including tomato, kiwifruit, pepper, olive and soybean, causing economic losses. Currently, chemicals and introduced resistance genes are used to protect plants against these pathogens but have limited success and may have adverse environmental impacts. Consequently, there is a pressing need to develop alternative strategies to combat bacterial disease in crops. One such strategy involves using narrow-spectrum protein antibiotics (so-called bacteriocins), which diverse bacteria use to compete against closely related species. Here, we demonstrate that one bacteriocin, putidacin L1 (PL1), can be expressed in an active form at high levels in Arabidopsis and in Nicotiana benthamiana in planta to provide effective resistance against diverse pathovars of Ps. Furthermore, we find that Ps strains that mutate to acquire tolerance to PL1 lose their O-antigen, exhibit reduced motility and still cannot induce disease symptoms in PL1-transgenic Arabidopsis. Our results provide proof-of-principle that the transgene-mediated expression of a bacteriocin in planta can provide effective disease resistance to bacterial pathogens. Thus, the expression of bacteriocins in crops might offer an effective strategy for managing bacterial disease, in the same way that the genetic modification of crops to express insecticidal proteins has proven to be an extremely successful strategy for pest management. Crucially, nearly all genera of bacteria, including many plant pathogenic species, produce bacteriocins, providing an extensive source of these antimicrobial agents.

Indexed as

BacteriocinsSolanum lycopersicumDisease ResistanceHumansPlant DiseasesPseudomonas syringaeBacteriocinsArabidopsisbacteriocinsdisease resistance antimicrobial peptideputidacin L1tobaccotransgenic

Identifiers

PMID31705720
PMCPMC7152609
OpenAlexW2983127398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.